Indication:Treatment of adults with chronic, accelerated, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) for whom no other tyrosine kinas

Dosage Form:Tablet

Active Ingredients:Pontinib

Route of Administration:Oral

Shelf Life:18 months

Storage:Below 30℃

Package:30 Or 90 Film Coated Tablets

Place of Origin:EU

Qualification:EU GMP

Dosage Form:Injection

Route of Administration:Subcutaneous Injection

Shelf Life:18 months

Storage:2℃-8℃

Qualification:Chinese GMP

Dosage Form:Cream

Route of Administration:Local Application

Shelf Life:18 months

Storage:Sealed

Qualification:Chinese GMP

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:For acne, acne and seborrheic dermatitis

Specification:external use. 2-3 times a day. Apply to the affected area

Dosage Form:Cream

Active Ingredients:Lincomycin and Vitamin B6

Route of Administration:Local Application

Shelf Life:2 years

Storage:Sealed

Package:20g per vial

Qualification:Chinese GMP

Indication:Lung cancer

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Powder

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:TONIC, As prescribed by physician.

Dosage Form:Others

Route of Administration:Oral

Shelf Life:18 months

Storage:Sealed

Qualification:EU GMP

Dosage Form:Others

Route of Administration:Oral

Shelf Life:3 years

Storage:Sealed

Qualification:FDA

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:Iohexol Injection is an X-ray contrast medium which is used in the blood vessels and body cavities of adults and children, in blood vessels, head and body CT-enhancement Lumba, Intravenous urography.

Specification:300mgI/ml,20ml/50ml/75ml/100ml; 350mgI/ml,20ml/50ml,200ml

Dosage Form:Injection

Active Ingredients:Iohexol

Route of Administration:Intravenous Drip

Shelf Life:3 years

Storage:Sealed

Package:1vial/box*10boxess/middle box*6 middle boxes/carton

Place of Origin:China

Qualification:Chinese GMP

Indication:Sepsis & acute pancreatitis

Dosage Form:Injection

Route of Administration:Subcutaneous Injection

Shelf Life:18 months

Storage:Sealed

Qualification:PICs GMP

CAS:125

Indication:slimming/weight loss

Specification:150mg-1600mg

Dosage Form:Capsule

Active Ingredients:as buyers' request

Route of Administration:Oral

Shelf Life:3 years

Storage:Below 30℃

Package:4000-20000

Place of Origin:China

Qualification:FDA

CAS:125

Indication:blood regulation

Specification:150mg-1600mg

Dosage Form:Capsule

Active Ingredients:as buyers' request

Route of Administration:Oral

Shelf Life:3 years

Storage:Below 30℃

Package:4000-20000

Place of Origin:China

Qualification:FDA

CAS:125

Indication:health/blood regulation

Specification:150mg-1400mg

Dosage Form:Capsule

Active Ingredients:as buyers' request

Route of Administration:Oral

Shelf Life:3 years

Storage:Below 30℃

Package:4000-20000

Place of Origin:China

Qualification:FDA

CAS:125

Indication:health/blood regulation

Specification:150mg-1400mg

Dosage Form:Capsule

Active Ingredients:as buyers' request

Route of Administration:Oral

Shelf Life:3 years

Storage:Below 30℃

Package:4000-20000

Place of Origin:China

Qualification:FDA

CAS:0003

Indication:Treatment of infections of the lower respiratory tracts, urinary tract, bile tract, and intraabdominal infections, intrapelvic infections, skin and soft tissue infections, bone and joint infections, s

Specification:BP/USP

Dosage Form:Injection

Active Ingredients:Ceftriaxone

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Below 25℃

Package:10 vials/box， 50vials /box

Place of Origin:Jining Shandong province

Qualification:Chinese GMP

CAS:23453

Indication:Orserdu (elacestrant) is an estrogen receptor antagonist indicated for the treatment of postmenopausal women or adult men, with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast c

Dosage Form:Tablet

Active Ingredients:elacestrant

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Package:Bottle

Place of Origin:india

Qualification:FDA